PAREXEL International Corporation operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PAREXEL International with three other
companies in this sector in the United States:
sales of $1.67 billion
Charles River Laboratories International Inc
of which 50%
was Discovery And Safety Assessment), and
PRA Health Sciences Inc
PAREXEL International reported sales of $2.10 billion
June of 2016.
increase of 4.1%
versus 2015, when the company's sales were $2.01 billion.
Sales at PAREXEL International have increased during each of the previous five years
(and since 2011, sales have increased a total of 47%).
Sales of Clinical Reserach Services saw an increase
5.9% in 2016, from
$1.54 billion to $1.63 billion.
Not all segments of PAREXEL International experienced an increase in sales in 2016:
sales of Parexel's Consulting Services fell 11.8% to $190.40 million.